Publications in collaboration with researchers from Hospital Universitario Virgen del Rocío (21)

2024

  1. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting

    Diabetes care, Vol. 47, Núm. 2, pp. 216-224

  2. Consequences of the poor therapeutic adherence in diabetes mellitus and improvement recommendations

    Atencion Primaria Practica, Vol. 6, Núm. 4

  3. Response to Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. Diabetes Care 2024;47:216-224

    Diabetes care, Vol. 47, Núm. 5, pp. e46-e47

  4. The Burden of Suboptimal Insulin Dosing in People with Diabetes in Spain: Barriers and Solutions from the Physician Perspective

    Patient Preference and Adherence, Vol. 18, pp. 151-164

2023

  1. Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital

    Endocrine Practice, Vol. 29, Núm. 11, pp. 919-927

  2. Changing trends in transgender demographics and morbidity: baseline data from a Spanish cohort

    Sexual health, Vol. 20, Núm. 1, pp. 96-98

  3. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

  4. Descriptive study of a clinical and educational telemedicine intervention in patients with diabetes receiving glargine 300 U/ml (Toujeo) in Spain: results of the T-Coach programme

    Drugs in Context, Vol. 12, pp. 1-11

  5. Effectiveness and Safety of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes Previously Treated with Continuous Subcutaneous Insulin Infusion and Flash Glucose Monitoring

    Diabetes technology & therapeutics, Vol. 25, Núm. 2, pp. 151-156

  6. Expert Consensus on Morphofunctional Assessment in Disease-Related Malnutrition. Grade Review and Delphi Study

    Nutrients, Vol. 15, Núm. 3

  7. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

    Journal of Diabetes Science and Technology, Vol. 17, Núm. 5, pp. 1326-1336

  8. Successful Use of an Advanced Hybrid Closed-loop System in a Patient With Type 3c Pancreatogenic Diabetes Secondary to Nesidioblastosis

    Canadian Journal of Diabetes, Vol. 47, Núm. 2, pp. 193-196

2022

  1. Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications

    Diabetes Therapy, Vol. 13, Núm. 5, pp. 873-888

  2. Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  3. Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study

    Drugs in Context, Vol. 11

  4. Flash Glucose Monitoring and Diabetes Mellitus Induced by Immune Checkpoint Inhibitors: An Approach to Clinical Practice

    Journal of Diabetes Research, Vol. 2022

  5. Once-Weekly Semaglutide Use in Patients with Type 2 Diabetes: Results from the SURE Spain Multicentre, Prospective, Observational Study

    Journal of Clinical Medicine, Vol. 11, Núm. 17

2021

  1. Covid-19 and diabetes

    Journal of Clinical Medicine, Vol. 10, Núm. 22

  2. DAPA-RWE: A retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain

    Journal of Comparative Effectiveness Research, Vol. 10, Núm. 10, pp. 815-821

  3. The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond

    Diabetes Therapy, Vol. 12, Núm. 9, pp. 2311-2327